Stages
100 articles
Clinical Trial For OncoTreat Being Developed
Researcher Kenneth Olive is developing OncoTreat, a method matches a patient’s tumor to the most effective drugs for their pancreatic cancer.
DIRECT Study Focuses on NanoKnife Technology
Dr. Daniel Holzwanger is part of the NanoKnife irreversible electroporation (IRE) study for stage III pancreatic cancer patients.
PATHFINDER Blood Test Trial Focused on Early Detection
Dr. Minetta Liu is part of the team conducting a clinical trial to find biomarkers that will become an easy blood test for pancreatic cancer.
The Future of Pancreatic Cancer Treatment
Dr. Anil Rustgi discusses the latest developments in pancreatic cancer treatment and the direction of current research in early detection.
An Interview with Dr. Tyler Jacks
Dr. Tyler Jacks is one of the leading pancreatic cancer researchers. Read what he has to say about KRAS, organoids, and running a lab in a pandemic.
Finding More Targets for Pancreatic Cancer Treatment
Dr. Noelle LoConte discusses a clinical trial for cancer patients, including pancreatic cancer patients, that have an NRG1 gene fusion.
Will New-Onset Diabetes Provide a Way to Detect Pancreatic Cancer Earlier?
Dr. Anirban Maitra, Dr. Suresh Chari, and others are looking at the relationship between new-onset diabetes and pancreatic cancer.
Pancreatic Cancer Science—2021 in Review
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
Liquid Biopsies: What You Should Know
Three different liquid biopsy blood tests are under development or now available for pancreatic and other cancers.
2022 AACR Annual Meeting Update
The 2022 AACR Annual Meeting featured the latest in pancreatic cancer breakthroughs, research in artificial intelligence, screening, detection, and vaccines.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
Identify Your Risk Early
Long-term survivor Scott Nelson was diagnosed with pancreatic cancer, so older brother Steve joined a screening study, which caught his cancer at its earliest stages.
Meet the Researcher: Nicolette Juliana Rodriguez, M.D., M.P.H.
Learn more about the research interests of Nicolette Rodriguez, M.D., M.P.H., one of the young investigators Let’s Win sponsored at AACR.
Compassionate Use: An Option Beyond Standard of Care
Investigational drugs can be accessed through the FDA’s compassionate use program. Learn more about how this can be used in pancreatic cancer treatments.